Foresite Capital Management IV as of Dec. 31, 2018
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 18 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding | 14.5 | $32M | 856k | 36.98 | |
| Insmed (INSM) | 11.9 | $26M | 2.0M | 13.12 | |
| Myokardia | 10.9 | $24M | 487k | 48.86 | |
| Cymabay Therapeutics | 9.5 | $21M | 2.6M | 7.87 | |
| Immunomedics | 7.9 | $17M | 1.2M | 14.27 | |
| Ascendis Pharma A S (ASND) | 7.1 | $15M | 245k | 62.65 | |
| Replimune Group (REPL) | 5.6 | $12M | 1.2M | 10.00 | |
| Rhythm Pharmaceuticals (RYTM) | 4.9 | $11M | 400k | 26.88 | |
| Optinose (OPTN) | 4.9 | $11M | 1.7M | 6.20 | |
| Orchard Therapeutics Plc ads | 4.8 | $11M | 668k | 15.73 | |
| Aerie Pharmaceuticals | 4.3 | $9.5M | 262k | 36.10 | |
| Arbutus Biopharma (ABUS) | 2.8 | $6.1M | 1.6M | 3.83 | |
| Eidos Therapeutics | 2.7 | $5.9M | 432k | 13.76 | |
| Aclaris Therapeutics (ACRS) | 2.5 | $5.5M | 748k | 7.39 | |
| Portola Pharmaceuticals | 2.2 | $4.9M | 250k | 19.52 | |
| Si-bone (SIBN) | 2.0 | $4.3M | 206k | 20.89 | |
| Kiniksa Pharmaceuticals | 0.8 | $1.8M | 64k | 28.10 | |
| Cytokinetics (CYTK) | 0.5 | $1.1M | 175k | 6.32 |
